167 related articles for article (PubMed ID: 7678722)
1. p53 expression in colorectal adenomas.
Kaklamanis L; Gatter KC; Mortensen N; Baigrie RJ; Heryet A; Lane DP; Harris AL
Am J Pathol; 1993 Jan; 142(1):87-93. PubMed ID: 7678722
[TBL] [Abstract][Full Text] [Related]
2. Frequently elevated content of immunochemically defined wild-type p53 protein in colorectal adenomas.
Tominaga O; Hamelin R; Trouvat V; Salmon RJ; Lesec G; Thomas G; Remvikos Y
Oncogene; 1993 Oct; 8(10):2653-8. PubMed ID: 8378077
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.
Mosnier JF; Perret AG; Vindimian M; Dumollard JM; Balique JG; Perpoint B; Boucheron S
Arch Pathol Lab Med; 1996 Jul; 120(7):654-9. PubMed ID: 8757470
[TBL] [Abstract][Full Text] [Related]
4. High frequency of p53 expression in colo-rectal adenomatous polyps.
Boccuzzi A; Terzolo M; Leonardo E; Cappia S; Tappero G; Paccotti P; Angeli A
Anticancer Res; 1995; 15(4):1407-10. PubMed ID: 7654029
[TBL] [Abstract][Full Text] [Related]
5. [The results of p53 immunostaining in colorectal adenomas, early cancers, advanced cancers and their hepatic metastasis].
Saigusa N; Maruyama K; Sugimura H; Endoh Y; Baba S
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():159-63. PubMed ID: 8678561
[TBL] [Abstract][Full Text] [Related]
6. Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers.
Sinicrope FA; Roddey G; Lemoine M; Ruan S; Stephens LC; Frazier ML; Shen Y; Zhang W
Clin Cancer Res; 1998 May; 4(5):1251-61. PubMed ID: 9607584
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of p53 overexpression in human colonic tumors.
Darmon E; Cleary KR; Wargovich MJ
Cancer Detect Prev; 1994; 18(3):187-95. PubMed ID: 8076381
[TBL] [Abstract][Full Text] [Related]
8. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis.
Sinicrope FA; Ruan SB; Cleary KR; Stephens LC; Lee JJ; Levin B
Cancer Res; 1995 Jan; 55(2):237-41. PubMed ID: 7812951
[TBL] [Abstract][Full Text] [Related]
9. A frequent alteration of p53 gene in carcinoma in adenoma of colon.
Ohue M; Tomita N; Monden T; Fujita M; Fukunaga M; Takami K; Yana I; Ohnishi T; Enomoto T; Inoue M
Cancer Res; 1994 Sep; 54(17):4798-804. PubMed ID: 8062281
[TBL] [Abstract][Full Text] [Related]
10. P53 protein immunohistochemical expression in colonic adenomas with and without associated carcinoma.
Saleh HA; Aburashed A; Bober P; Tabaczka P
Am J Gastroenterol; 1998 Jun; 93(6):980-4. PubMed ID: 9647033
[TBL] [Abstract][Full Text] [Related]
11. [Expression of P53 and heat shock protein in colorectal tumors: an immunohistochemical study].
Morimoto H; Monden T; Miyoshi Y; Kawasaki Y; Nakanishi H; Shimano T; Mori T
Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1094-7. PubMed ID: 1944162
[TBL] [Abstract][Full Text] [Related]
12. Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma.
Kondo Y; Arii S; Furutani M; Isigami S; Mori A; Onodera H; Chiba T; Imamura M
Cancer; 2000 Apr; 88(8):1820-7. PubMed ID: 10760758
[TBL] [Abstract][Full Text] [Related]
13. [Expression of p53 and bcl-2 in colorectal adenomas and carcinomas].
Sundblad AS; Chumbita RL; Zoppi JA
Medicina (B Aires); 1997; 57(6):662-6. PubMed ID: 9674186
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
[TBL] [Abstract][Full Text] [Related]
15. Expression of brain-type glycogen phosphorylase is a potentially novel early biomarker in the carcinogenesis of human colorectal carcinomas.
Tashima S; Shimada S; Yamaguchi K; Tsuruta J; Ogawa M
Am J Gastroenterol; 2000 Jan; 95(1):255-63. PubMed ID: 10638593
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
[TBL] [Abstract][Full Text] [Related]
17. p53 expression in colorectal tumors.
Purdie CA; O'Grady J; Piris J; Wyllie AH; Bird CC
Am J Pathol; 1991 Apr; 138(4):807-13. PubMed ID: 1707233
[TBL] [Abstract][Full Text] [Related]
18. p53 and bcl-2 protein expression in rectosigmoid adenomas.
Papatheodoridis GV; Kapranos N; Tzouvala M; Triantafyllou K; Elemenoglou I; Karamanolis DG
Am J Gastroenterol; 1998 Jul; 93(7):1136-40. PubMed ID: 9672345
[TBL] [Abstract][Full Text] [Related]
19. VEGF expression in the colorectal adenoma-carcinoma sequence.
Kaklamanis L; Trichas M; Amarantidis K; Spathari N; Micheli A; Karayiannakis A; Chatzaki E; Georgoulias V; Kakolyris S
Oncol Res; 2006; 15(9):445-51. PubMed ID: 16555551
[TBL] [Abstract][Full Text] [Related]
20. Adenomas of the colon: overexpression of p53 protein and risk factors.
Speroni AH; Vanzulli SI; Meiss RP
Endoscopy; 1998 Sep; 30(7):623-6. PubMed ID: 9826142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
